HUBEI PROVINCE, CHINA--(MARKET WIRE)--Sep 24, 2007 -- Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTC BB:BPMA.OB - News), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced today that results following clinical trials, presented at its national forum on “Gene Therapy for Tumors” on September 9, 2007, were met with such overwhelming enthusiasm that physicians present immediately placed orders for 16,000 vials, effectively buying out all available product in just one day; when realized, these sales are expected to total $3.8 million. By way of comparison, sales of Gendicine® through the entire first half of the year totaled $1.5 million.
